Vyant Bio Inc

NASDAQ:VYNT   3:16:30 PM EDT
0.59
+0.01 (+2.47%)
Earnings Announcements

Vyant Bio Reports Second Quarter And First Half 2022 Results

Published: 08/22/2022 20:42 GMT
Vyant Bio Inc (VYNT) - Vyant Bio Reports Second Quarter and First Half 2022 Results and Provides Strategic and Business Highlights.
Vyant Bio Inc - Expects Cash Runway for Approximately 18 Months.
Vyant Bio Inc Qtrly Loss per Share $0.20.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.14

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.13

More details on our Analysts Page.